OC-09: Rivaroxaban compared to no treatment in early breast cancer patients (the TIP Trial): initial findings for a phase II preoperative window-of-opportunity randomised controlled trial. Issue 213 (May 2022) - Kirwan, C.C.; Castle, J.; Pritchard, S.A.; Bundred, N.J.; Thachill, J.; Harvey, J.R.; Roy, P.G.; Volleamere, A.; Blower, E.L.; Palmieri, C.; Hogan, B.; Vinayagam, R.; et al.